VERU INC. Accounts Receivable, Allowance for Credit Loss
VERU INC. (VERU) had Accounts Receivable, Allowance for Credit Loss of $3.92 million as of 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2024-05-08
- 2024-03-31: Accounts Receivable, Allowance for Credit Loss $3.92M.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss $3.92M.
- 2023-09-30: Accounts Receivable, Allowance for Credit Loss $3.92M.
- 2023-06-30: Accounts Receivable, Allowance for Credit Loss $3.92M.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2024-03-31 | $3.92M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.92M 10-Q · filed 2024-04-01 |
| 2023-09-30 | $3.92M 10-Q · filed 2024-05-08 |
| 2023-06-30 | $3.92M 10-Q/A · filed 2023-11-15 |
| 2023-03-31 | $3.92M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $12.14K 10-Q · filed 2023-02-09 |
| 2022-09-30 | $12.14K 10-Q · filed 2024-05-08 |
| 2022-06-30 | $14.14K 10-Q/A · filed 2023-11-15 |
| 2022-03-31 | $16.64K 10-Q · filed 2023-05-11 |
| 2021-12-31 | $18.64K 10-Q · filed 2022-02-09 |
| 2021-09-30 | $20.64K 10-K/A · filed 2024-04-01 |
| 2021-06-30 | $22.64K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $24.64K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $25.64K 10-Q · filed 2021-02-10 |
| 2020-09-30 | $25.64K 10-K · filed 2021-12-02 |
| 2020-06-30 | $25.64K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $25.64K 10-Q · filed 2020-05-13 |
| 2019-09-30 | $33.14K 10-K · filed 2021-12-02 |
| 2019-06-30 | $33.14K 10-Q · filed 2020-08-13 |
| 2019-03-31 | $36.20K 10-Q · filed 2020-05-13 |
| 2018-09-30 | $36.20K 10-K · filed 2020-12-10 |
| 2015-12-31 | $48.07K 10-Q · filed 2016-02-02 |
| 2015-09-30 | $48.07K 10-Q · filed 2016-02-02 |
| 2015-06-30 | $48.07K 10-Q · filed 2015-07-30 |
| 2015-03-31 | $48.07K 10-Q · filed 2015-04-30 |
| 2014-12-31 | $48.07K 10-Q · filed 2015-02-03 |
| 2014-09-30 | $48.07K 10-K · filed 2015-12-02 |
| 2014-06-30 | $13.18K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $13.18K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $13.18K 10-Q · filed 2014-02-03 |
| 2013-09-30 | $13.18K 10-K · filed 2015-12-02 |
| 2013-06-30 | $68.69K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $23.01K 10-Q · filed 2013-05-02 |
| 2012-12-31 | $23.01K 10-Q · filed 2013-01-30 |
| 2012-09-30 | $41.63K 10-K · filed 2015-12-02 |
| 2012-06-30 | $52.00K 10-Q · filed 2012-07-31 |
| 2011-09-30 | $10.00K 10-K · filed 2014-12-02 |
| 2010-09-30 | $39.80K 10-K · filed 2013-12-03 |
| 2009-09-30 | $39.80K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |